Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Engineering thiol-ene click chemistry for the preparation of a chiral stationary phase based on a [4+6]-type homochiral porous organic cage for enantiomeric separation in normal-phase and reversed-phase high performance liquid chromatography.
Liang RX, Zhang YP, Zhang JH, Gong YN, Huang B, Wang BJ, Xie SM, Yuan LM. Liang RX, et al. Among authors: xie sm. J Chromatogr A. 2023 Nov 22;1711:464444. doi: 10.1016/j.chroma.2023.464444. Epub 2023 Oct 11. J Chromatogr A. 2023. PMID: 37837712
UBR4 deficiency causes male sterility and testis abnormal in Drosophila.
Xie SM, Lai JX, Liu CQ, Zhang XX, Lin YM, Lan QW, Hong DY, Chen XC, Qiao JD, Mao YL. Xie SM, et al. Front Endocrinol (Lausanne). 2023 Jul 10;14:1165825. doi: 10.3389/fendo.2023.1165825. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37529615 Free PMC article.
A novel pillar[3]trianglimine macrocycle with a deep cavity used as a chiral selector to prepare a chiral stationary phase by thiol-ene click reaction for enantioseparation in high-performance liquid chromatography.
Liang RX, Ma QY, Xiang TX, Zhang YP, Gong YN, Huang B, Wang BJ, Xie SM, Zhang JH, Yuan LM. Liang RX, et al. Among authors: xie sm. J Sep Sci. 2023 Sep;46(18):e2300376. doi: 10.1002/jssc.202300376. Epub 2023 Jul 31. J Sep Sci. 2023. PMID: 37525411
Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment.
Liu S, Xie SM, Liu W, Gagea M, Hanker AB, Nguyen N, Singareeka Raghavendra A, Yang-Kolodji G, Chu F, Neelapu SS, Marchese A, Hanash S, Zimmermann J, Arteaga CL, Tripathy D. Liu S, et al. Among authors: xie sm. Breast Cancer Res. 2023 Jun 6;25(1):62. doi: 10.1186/s13058-023-01665-w. Breast Cancer Res. 2023. PMID: 37280713 Free PMC article.
119 results